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Epidermolysis bullosa refers to a clinically and genetically heterogeneous group of inherited mucocu-
taneous diseases. Laryngotracheal lesions are momentous regarding the risk of sudden airway
obstruction. The traditional treatment is tracheostomy. This case report highlights the advantages of
minimally invasive interventions. A successful combined endoscopic management of a life-threatening
respiratory crisis is presented in a 4-year-old child. Combined commissure stenosis with supraglottic
spread was treated by CO2 laser dissection and bilateral endoscopic arytenoid abduction lateropexy,
supplemented with mitomycin C application. Due to expectable less scarring, the combination of these
modern methods may be an efﬁcient solution in these vulnerable respiratory tracts.
© 2016 Elsevier Ireland Ltd. All rights reserved.1. Introduction
Epidermolysis bullosa (EB) is a group of inherited disorders
characterized by mucocutaneous fragility due to genetic defects in
structural proteins of the skin. Besides blister formations and ero-
sions on the skin and mucous membranes, extracutaneous mani-
festations such as oro-pharyngeal, laryngeal, ocular,
gastrointestinal, genitourethral stenosis, scarring, anemia, con-
tractures, malignancy, cardiovascular symptoms and psychological
problems can complicate the patients' lives. Symptoms can range
from mild to lethal, from minimal mucosal and visceral involve-
ment to the most severe recessive formwith several cutaneous and
extracutaneous lesions inﬂuencing lifetime and quality of life [1].
The natural history of inherited EB varies signiﬁcantly across
subtypes. Nowadays, more than 1000 mutations on at least 14
structural genes have been documented in the literature of EB [2].
Four major types and at least 30 subtypes are differentiated ac-
cording to the related structural protein and level of the blisters:
simplex (EBS; epidermolytic), junctional (JEB; lucidolytic), dystro-
phic EB (DEB; dermolytic), and Kindler syndrome (mixed levels ofo).
rved.blistering) [1e3]. Primary diagnosis relies on speciﬁc clinical fea-
tures and pathological analysis. Today the immunoﬂuorescence
mapping is considered as gold standard in the diagnosis. The
structural proteins of the basal membrane zone are detected with
speciﬁc antibodies, this technique shows the level of the defect and
the amount of protein expression [2,3].
The onset of EB is usually at birth, or shortly after, thus mild
cases can remain undetected [1]. Respiratory tract involvement,
especially laryngeal lesions mostly occur in JEB [4]. Signs and
symptoms can vary from mild to severe, life-threatening: weak or
hoarse cry, inspiratory stridor, edema, blistering of mucosa, thick-
ening and scarring of the vocal cords, cicatrical lesions or severe
upper airway stenosis.
According to the literature tracheostomy should be considered
early in any child with EB and laryngotracheal involvement to avoid
life-threatening airway obstruction and further iatrogenic injuries
[4,5]. Endoscopic management is thought to play secondary role
due to the vulnerability of the tissues.
In this case report, we present a history of a child with JEB
suffered from severe, extended laryngeal stenosis. The well-
designed, combined minimally invasive endoscopic procedures
provided satisfactory result without tracheostomy.
Fig. 1. Preoperative picture: combined anterior (a) and posterior glottic stenosis (b)
with supraglottic spread into the interarytenoid region (c).
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A 4-year-old girl was admitted to our clinic with life-threatening
inspiratory stridor. JEB was diagnosed since no breathing difﬁ-
culties were detected at birth and only blister formations were
present on her face. Before her admission she had dyspnea for a
year. The severe inspiratory dyspnea necessitated an urgent sur-
gical intervention.
In supraglottic jet ventilation (AcutronicAms® 1000 device with
the following parameters: inhalation time: 40e50%; frequency:
50e60/min; volume: 3e400ml; respiratory minute volume:
1,8e2,4l; pressure: 50 mbar (Acutronic Medical System AG, Hirzel
Switzerland) and total intravenous narcosis (25 mg/kg propofol
(1%), 10 mg/kg fentanyl, 1 mg/kg mivacurium) direct laryngoscopy
was performed. For safety reasons 8 mg/kg methylprednisolone
(Solu-medrol®) and 15 mg/kg meropenem (Meropenem®) were
administered at the introduction of anesthesia. The larynx was
approached through a Weerda laryngoscope. A combined severe
multilevel laryngeal stenosis was observed: anterior and posterior
commissure stenosis with supraglottic spread into the interar-
ytenoid region. Thus, a pinhead-sized airway was only detectable
(Fig. 1).
To avoid tracheostomy minimally invasive transoral laser
resection was performed as a deﬁnitive solution. Firstly, the ante-
rior and posterior commissure and the supraglottic interary area
adhesions were dissolved by ultra dream pulse (UDP) mode
CO2laser (Dhaesin U-40; peak power: 252 W; relaxation time:
500 ms; duration time: 5 ms) until proper mobility of the arytenoid
cartilages could be achieved.
A Bogdasarian-Olson [6] type 2 posterior (the scars spread into
the interarytenoid space) and a Cohen [7] type 2 anterior glottic
stenosis (web involving 35e50% of the glottis) were conﬁrmed
(Fig. 2a and b).
In our experiences, in accordance with international observa-
tions without any further interventions severe restenosis may
occur in the near future because of the large row facing wound
surfaces in the larynx. Earlier we suggested a surgical method
designed for other isolated posterior glottic stenosis: a bilateral
endoscopic arytenoid abduction lateropexy (EAAL) by endolar-
yngeal thread guide instrument (ETGI) was performed to keep the
facing areas apart from each other [8,9], (Fig. 2c). After this fast and
straight forward maneuver a maximal physiological abducted po-
sition was created by suture-lateralization of the arytenoid carti-
lages [10].
Originally, we planned to place a temporary silicon stent into the
anterior commissure, but the large angle of the anterior
commissuree considering the high vulnerability of the mucosa
elet us to abandon this intervention. After the uneventful awak-
ening procedure adequate airway and breathing were observed and
the child was delivered to the ICU for observation. Reintubation or
ventilation was not necessary. In the postoperative period antibi-
otics (3  15 mg/kg meropenem: Meropenem®) and steroids
(2  3 mg/kg methylprednisolone: Solu-medrol®) were adminis-
trated intravenously for 5 days.
One week later, control direct laryngoscopy showed a wide
adequate airway, and mitomycin c (MMC) (1 mg/ml for 5 min), an
antiproliferative agent was applied on the wound surfaces. 3-
months-postoperative direct laryngoscopy conﬁrmed no sign of
restenosis. After removing the bilateral lateralizing sutures through
a short skin incision, regainedmobility of both cricoarytenoid joints
was detected (Fig. 3).
Follow up examinations were performed every third month in
the ﬁrst year. At the end of the third postoperative year the child is
free from any symptoms.
Postoperatively voice and life quality was evaluated by voiceanalysis, Voice Handicap Index (VHI) and Quality of Life question-
naire (QoL) [11]. The objective voice analysis and the VHI showed a
continuous improvement of her voice to normal level in Jitter,
Schimmer (Fig. 4) and harmonic to noise ratio (HNR) (Fig. 5).
However, the mean phonation time was very short. It might be
explained by the patients' age-related cooperation difﬁculties. By
the evaluation of her mother, VHI has become excellent after a year.3. Discussion
The nature of EB makes the management of these children
difﬁcult and demanding. Each manipulation may cause de novo
lesions on the laryngeal mucosa, which can exasperate the already
poor respiratory status [4]. Secondly, the anatomical situation, the
small airways in early childhood, the great demand of open surgery,
the possible impairment of swallowing and speech development
and the resulting technical issues play remarkable role in pediatric
airway surgery. High skills and experiences of the surgeon are
indispensable for avoiding inducing further lesions.
In 1978 Ramadass and Thangavelu [12] were the ﬁrst to report
laryngeal involvement in EB and the ﬁrst to suggest tracheostomy
as a deﬁnitive treatment. Since then, several cases, publications
have conﬁrmed that laryngotracheal lesions may play an important
role for EB patients, especially in JEB [12e16].
A retrospective study published by Fine et al. [13] used 3280
cases of the National Registry of Bullous Epidermolysis of the USA
to deﬁne the frequency of upper airway complications and assess
the cumulative risk of laryngeal stenosis in EB patients. The most
common laryngeal complication was chronic hoarseness occurring
in 7% of EBS. It occurred most frequently in JEB types, 33% in non-
Herlitz JEB (JEB-nH) and 50% in JEB-Herlitz (JEB-H). JEB-H subtype
is the most severe and usually fatal form, associated with the
absence of laminin-332 (laminin-5) expression. JEB-nH has better
prognosis, it results from reduced expression of this glycoprotein
[2,14].
Lifetable analysis predicted the cumulative risk of severe upper
airway stenosis or obstruction, which has provided an outcome of
13% and 40% at the age of 1 and 6, in JEB-H respectively and 8.3% at
the age of 1 and 12.75% after the age of 9 in JEB-nH [13].
Monitoring in the ﬁrst years of life is inevitable for identifying
the early laryngotracheal symptoms. Fine et al. estimated, that
approximately 10% and 23% of JEB-H and JEB-nH patients had died
probably from airway obstruction (excluding pneumonia, sepsis,
failure to thrive and renal failure). They concluded that each EB
child with laryngeal symptoms should be electively
Fig. 2. Intraoperative pictures: laser dissection of posterior (a) and anterior (b) commissure; bilateral endoscopic arytenoid lateropexy (c).
Fig. 3. 3-months postoperative picture after the removal of the lateralizing sutures from external incision: the regained mobility of the cricoarytenoid joints can be seen during
sleeping right after the procedure (a) normal (b) open position.
Fig. 4. Results of voice analysis I.: Jitter, Schimmer.
Fig. 5. Results of voice analysis II.: HNR.
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Despite solving respiratory status, tracheostomy requires
further reconsiderations regarding its inﬂuence on swallowing and
speech development, social and emotional life [17e20]. Due to the
extremely vulnerable tissue, the long-lasting cannula wearing may
induce erosions, blistering, de novo stenosis and accumulation of
ﬁbrin or mucous [4].
According to the literature tracheostomy might be the solutionfor difﬁcult, extended cases. Mellerio [15], Hore [14], Babic [4] et al.
reported altogether 8 cases with airway involvement, in which
tracheostomywas not the ﬁrst chosen therapy, conservative steroid
or adrenalin nebulizer was applied, but in six out of eight cases
tracheostomy could not be avoided. Minimally invasive transoral
procedures played only secondary role: Hore [14] et al. used laser
dissection and topical MMC application as additional treatment to
facilitate decannulation after tracheostomy, which was successful
in two cases.
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vantages of tracheostomy, we performed a deﬁnitive minimally
invasive combined endoscopic surgery for a life-threatening upper
airway stenosis without tracheostomy: CO2 scar dissection fol-
lowed by bilateral EAAL and delayed MMC application.
For the dissection of the combined commissure stenosis modern
CO2 laser was used in UDP mode. This recently developed new
mode accompanied with micro-spot technique has been intro-
duced to reduce thermal tissue damage and minimize the necrotic
zone. Setting of relaxation time decreases thermal spread by
allowing the surrounding heated tissues to cool down [21]. The
possibility of using high peak power and achieve less tissue damage
by impulsive mode may simplify its use in pediatric airway surgery,
especially in more vulnerable cases like EB patients.
In our prior article e following the international recommenda-
tions - we suggested a combined silicone tube-sheet stent insertion
into the anterior commissure until wound healing [22]. However it
was conﬁrmed in our recent cadaver morphometric study [23], that
a sufﬁciently large angle could be achieved in the anterior
commissure by EAAL, especially after bilateral intervention.
Considering the anatomy of the pediatric larynx, even larger angles
might be reached in children, than in adults. The angle was large
enough to maintain an optimal distance between the vocal folds
[24], which necessitated no stent insertion. Bilateral arytenoid
abduction provided an optimally wide airway functioning as a
temporary hidden stent by keeping the freemucosal surfaces apart,
preventing restenosis in the posterior commissure. The lateralizing
sutures were placed under the skin, they caused no skin irritation.
Stent emplacement (accompanied with temporary tracheos-
tomy) could have been a useful method to avoid restenosis, but in
these vulnerable tissues, it might aggravate the situation by further
mucosal damage.
The topically applied MMC is functioning as an antiproliferative
agent by inhibiting RNA and protein synthesis. Regarding the
management of vocal fold scarring, it has been shown to lead to
reduced anterior glottis web formation, decreased total collagen
deposition, improved cricoarytenoid joint mobility, and decreased
granulation tissue development [22,25,26]. Although the exact use,
dosage and timing of MMC are controversial in the literature, an
optimal balance should be found to control scar formation, but
allow the necessary repair of tissue. Delayed application of MMC
seems to be effective. One would expect a better result, if MMC is
applied during the cell proliferation phase at the end of the ﬁrst
postoperative week, when ﬁbroblasts are present in the tissue and
active in collagen secretion [26].
4. Conclusion
The management of pediatric upper airway stenosis is still a
great challenge especially for childrenwith EB. The young age of the
patients, the small size of the larynx, the nature of the disease and
the possibility of sudden airway obstruction increase the
complexity of the problem. Direct surgical interventions have been
proposed only for milder cases, tracheostomy is suggested for se-
vere ones. Our case proved that introducing a new concept of
treatment strategy: modern laser surgery, endoscopic arytenoid
abduction lateropexy and mitomycin c might provide excellent
result even in difﬁcult cases.
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